Literature DB >> 11723541

The development of antioxidant defense mechanism in young rat embryos in vivo and in vitro.

V Zaken1, R Kohen, A Ornoy.   

Abstract

Reactive oxygen species (ROS) are involved in the etiology of numerous diseases and are suggested to be one of the mechanisms of action of several teratogens such as cocaine, high concentrations of glucose and ketone bodies. We studied the antioxidant capacity of 9.5-12.5 day old rat embryos and their yolk sacs both in vivo and in vitro. We measured the activity of superoxide dismutase (SOD) and the hydrogen peroxide removing activity (mainly due to catalase (CAT) and glutathione peroxidase (GSH -Px) and found significant activity of these enzymes already at day 9.5 in the embryos and their yolk sac, both in vivo and in vitro. A gradual increase in the activity was found with the advancement of embryonic age. The reducing power, that reflects the concentration of low molecular weight antioxidants (LMWA) was measured by cyclic voltammetry. LMWA were found in the embryos and their yolk sacs on days 9.5-11.5 of gestation with the peak potential of 0.56- 0.62 Volts. On day 12.5 an additional group of LMWA appeared at a peak potential of 0.95-0.97 Volts. There was a gradual increase in the concentration of LMWA with the increase in embryonic age. Generally, the concentration of LMWA was higher in the embryo than in its yolk sac but it was similar in vivo and in vitro at the same developmental stage. The gradual development of the embryonic antioxidant capacity implies that under normal conditions the developing embryo is capable of coping with oxidative stress, but this may fail under various pathological conditions, leading to embryonic damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11723541

Source DB:  PubMed          Journal:  Early Pregnancy        ISSN: 1537-6583


  5 in total

1.  Association of copper-zinc superoxide dismutase (SOD1) and manganese superoxide dismutase (SOD2) genes with nonsyndromic myelomeningocele.

Authors:  Benjamin A Kase; Hope Northrup; Alanna C Morrison; Christina M Davidson; Amanda M Goiffon; Jack M Fletcher; Kathryn K Ostermaier; Gayle H Tyerman; Kit Sing Au
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-09-13

Review 2.  Nrf2 and Nrf2-related proteins in development and developmental toxicity: Insights from studies in zebrafish (Danio rerio).

Authors:  Mark E Hahn; Alicia R Timme-Laragy; Sibel I Karchner; John J Stegeman
Journal:  Free Radic Biol Med       Date:  2015-06-28       Impact factor: 7.376

3.  Novel single nucleotide polymorphisms in the superoxide dismutase 1 and 2 genes among children with myelomeningocele.

Authors:  Benjamin A Kase; Hope Northrup; Kit Sing Au
Journal:  Am J Obstet Gynecol       Date:  2013-06-20       Impact factor: 8.661

4.  Effects of alpha-lipoic acid supplementation on maternal diabetes-induced growth retardation and congenital anomalies in rat fetuses.

Authors:  M H M Al Ghafli; R Padmanabhan; H H Kataya; B Berg
Journal:  Mol Cell Biochem       Date:  2004-06       Impact factor: 3.396

5.  Embryo-Protective Effects of Cerium Oxide Nanoparticles against Gestational Diabetes in Mice.

Authors:  Zeinab Vafaei-Pour; Mohammad Shokrzadeh; Monireh Jahani; Fatemeh Shaki
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.